Unit of drugmaker Insys pleads guilty to U.S. opioid bribe scheme

FILE PHOTO: John Kapoor, the billionaire founder of Insys Therapeutics Inc., leaves the federal courthouse in Boston, Massachusetts, U.S., March 13, 2019. REUTERS/Brian Snyder/File Photo/File Photo

BOSTON (Reuters) – A unit of Insys Therapeutics Inc pleaded guilty on Friday to fraud charges as part of an $225 million deal with the U.S. Justice Department resolving claims that the drugmaker bribed doctors to prescribe an addictive opioid medication. The plea, in federal court in Boston by the Chandler, Arizona-based Insys’ operating subsidiary, […]

Continue reading this article with a Fiji Times online membership.

More Stories